News Headlines Article

UC San Francisco finds possible new HIV vaccine or treatment target
San Francisco Business Times

Researchers at the University of California, San Francisco studying a virus similar to HIV that infects monkeys found a possible new target for vaccines or treatment in humans. Dennis Hartigan-O’Connor, M.D., of UCSF led the study, which found that rhesus monkeys (Macaca mulatta) with more of a certain type of immune cell, called Th17, in their gut, had lower virus levels in their blood for six months after infection with SIV, or simian immunodeficiency virus.